1887
Volume 2021, Issue 2
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Background: Clinical data on Coronavirus Disease 2019 (COVID-19) in solid organ transplant (SOT) recipients are limited. We herein report the initial clinical experience with COVID-19 in SOT recipients in Qatar.

Methods: All SOT recipients with laboratory-confirmed COVID-19 up to May 23, 2020 were included. Demographic and clinical data were extracted retrospectively from the hospital’s electronic health records. Categorical data are presented as frequency and percentages, while continuous variables are summarized as medians and ranges.

Results: Twenty-four SOT recipients with COVID-19 were identified (kidney 16, liver 6, heart 1, and liver and kidney 1). Organ transplantation preceded COVID-19 by a median of 60 months (range 1.7–184). The median age was 57 years (range 24–72), and 9 (37.5%) transplant recipients were females. Five (21%) asymptomatic patients were diagnosed through proactive screening. For the rest, fever (15/19) and cough (13/19) were the most frequent presenting symptoms. Five (20.8%) patients required invasive mechanical ventilation in the intensive care unit (ICU). Eleven (46%) patients developed acute kidney injury, including three in association with drug-drug interactions involving investigational COVID-19 therapies. Maintenance immunosuppressive therapy was modified in 18 (75%) patients, but systemic corticosteroids were not discontinued in any. After a median follow-up of 226 days (26–272), 20 (83.3%) patients had been discharged home, 2 (8.3%) were still hospitalized, 1 (4.2%) was still in the ICU, and 1 (4.2%) had died.

Conclusions: Our results suggest that asymptomatic COVID-19 is possible in SOT recipients and that overall outcomes are not uniformly worse than those in the general population. The results require confirmation in large, international cohorts.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2021.23
2021-08-10
2021-09-27
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2021/2/qmj.2021.23.html?itemId=/content/journals/10.5339/qmj.2021.23&mimeType=html&fmt=ahah

References

  1. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. 2021. Available from: https://covid19.who.int (accessed Jan 14, 2021).
  2. World Health Organization. Clinical management of COVID-19 – interim guidance 27 May 2020. 2020. Available from: https://apps.who.int/iris/handle/10665/332196 (accessed Jan 14, 2021).
  3. Manuel O, Estabrook M, . American Society of Transplantation Infectious Diseases Community of Practice. RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:(9):e13511.
    [Google Scholar]
  4. Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and Solid Organ Transplantation: A Review Article. Transplantation. 2021; 105:(1):37–55.
    [Google Scholar]
  5. Siddiqi HK, Mehra MR. COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal. J Heart Lung Transplant. 2020; 39:(5):405–7.
    [Google Scholar]
  6. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. Section 2: AKI Definition. Kidney Int Suppl (2011). 2012;2(1):19–36.
  7. Kimball A, Hatfield KM, Arons M, James A, Taylor J, Spicer K, et al. Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility – King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020; 69:(13):377–81.
    [Google Scholar]
  8. Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, et al. COVID-19 in Solid Organ Transplant Recipients: Initial Report from The US Epicenter. Am J Transplant. 2020; 20:(7):1800–8.
    [Google Scholar]
  9. Fernandez-Ruiz M, Andres A, Loinaz C, DelgadoJF, Lopez-Medrano F, San JuanR, et al. COVID-19 in Solid Organ Transplant Recipients: A Single-Center Case Series from Spain. Am J Transplant. 2020;10.1111/ajt.15929.
    [Google Scholar]
  10. Zhong Z, Zhang Q, Xia H, Wang A, Liang W, Zhou W, et al. Clinical Characteristics and Immunosuppressant Management of Coronavirus Disease 2019 in Solid Organ Transplant Recipients. Am J Transplant. 2020; 20:(7):1916–21.
    [Google Scholar]
  11. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382:(19):1787–99.
    [Google Scholar]
  12. Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J, et al. Association of Treatment with Hydroxychloroquine or Azithromycin with In-Hospital Mortality in Patients With COVID-19 in New York State. JAMA. 2020; 323:(24):2493–502.
    [Google Scholar]
  13. Monostory K. Metabolic Drug Interactions with Immunosuppressants. In: Tsoulfas G, editor. Organ Donation and Transplantation. Current Status and Future Challenges. IntechOpen. 2018. Available from: https://www.intechopen.com/books/organ-donation-and-transplantation-current-status-and-future-challenges/metabolic-drug-interactions-with-immunosuppressants..
    [Google Scholar]
  14. Bartiromo M, Borchi B, Botta A, Bagala A, Lugli G, Tilli M, et al. Threatening Drug-Drug Interaction in a Kidney Transplant Patient with Coronavirus Disease 2019 (COVID-19). Transpl Infect Dis. 2020; 22:(4):e13286.
    [Google Scholar]
  15. Meziyerh S, Zwart TC, van Etten RW, JansonJA, van Gelder T, Alwayn IPJ, et al. Severe COVID-19 in a Renal Transplant Recipient: A Focus on Pharmacokinetics. Am J Transplant. 2020; 20:(7):1896–901.
    [Google Scholar]
  16. The RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021; 384:(8):693–704.
    [Google Scholar]
  17. Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy. Kidney Int Rep. 2020; 5:(5):580–5.
    [Google Scholar]
  18. Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan DC, et al. Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement. Hepatology. 2020; 72:(1):287–304.
    [Google Scholar]
  19. Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, et al. Viral Dynamics in Mild and Severe Cases of COVID-19. Lancet Infect Dis. 2020; 20:(6):656–7.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2021.23
Loading
/content/journals/10.5339/qmj.2021.23
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): coronavirus , middle east , Qatar , SARS-CoV-2 and transplantation
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error